Life expectancy and healthcare costs for patients with rheumatoid arthritis

A new study published in Arthritis & Rheumatology suggests that recent advances in the treatment of rheumatoid arthritis have prolonged patients' lives but also increased healthcare costs.

For the study, examined medical claims data from the National Health Insurance of Taiwan, identifying 29,352 new cases of rheumatoid from 2003-2016.

The life expectancy after rheumatoid arthritis diagnosis was 26.3 years, and the lifetime cost was estimated to be US $72,953 after disease-modifying antirheumatic drugs called biologics became available in 2003.

"After the availability of biologics, rheumatoid arthritis patients appeared to live longer with higher lifetime expenditures that should be monitored and evaluated for cost-effectiveness," the authors wrote.


Explore further

Link between periodontitis and cardiovascular disease in individuals with rheumatoid arthritis

More information: Arthritis & Rheumatology, DOI: 10.1002/art.41597
Provided by Wiley
Citation: Life expectancy and healthcare costs for patients with rheumatoid arthritis (2020, December 9) retrieved 18 January 2021 from https://medicalxpress.com/news/2020-12-life-healthcare-patients-rheumatoid-arthritis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments